BUSINESS

Iridex Reports First Quarter 2026 Loss, Mixed Results

PUBLISHED May 19, 2026, 5:26 PM ET

Read, Watch or Listen

Media Bias Meter

Sources: 10

Center 100%

Sources: 10

Mountain View, California — On May 19, 2026, Iridex Corporation reported a $524,000 net loss for the first quarter ended April 4, 2026, and revenue of $11.8 million. The Mountain View-based medical laser manufacturer disclosed a loss of three cents per share and released its quarterly figures this week. Company filings show gross profit of $4.7 million and a 40% gross margin, down from $5.0 million and 43% a year earlier, and operating expenses of $5.1 million. Management attributed margin pressure to higher manufacturing costs and tariff developments and noted an ongoing transition to lower-cost contract manufacturers as part of cost-savings efforts.

By Sarah Whitman | JQJO News

Timeline of Events

Quarter ended April 4, 2026: operational period for Q1 reporting.
May 19, 2026: Iridex issued Q1 2026 financial results via GlobeNewswire.
May 19, 2026: Benzinga and AP-distributing outlets published the Q1 results.
Company cited higher manufacturing costs and tariff impacts as drivers of margin decline.
Company confirmed continued transition to lower-cost contract manufacturers and noted modest operating expense reductions.

News Intelligence

Iridex's financial health can impact the cost of medical lasers, potentially affecting healthcare costs. If you're in the medical field, keep an eye on how this plays out. For investors, it's a reminder to watch for tariff impacts and manufacturing costs in your portfolio companies.

Media Bias

Articles Published:: 10
Right Leaning:: 0
Left Leaning:: 0
Neutral:: 10

Who Benefited

Contract manufacturers and component suppliers benefited from Iridex’s announced transition to lower-cost contract manufacturing, creating increased production opportunities and potential new revenue streams as the company reshapes its supply chain.

Who Impacted

Iridex shareholders and near-term profitability experienced negative impact as higher manufacturing costs and tariff developments contributed to a $524,000 Q1 net loss and a reduced gross margin.

Media Bias

Articles Published:: 10
Right Leaning:: 0
Left Leaning:: 0
Neutral:: 10
Distribution:: Left 0%, Center 100%, Right 0%

Who Benefited

Who Impacted

Iridex shareholders and near-term profitability experienced negative impact as higher manufacturing costs and tariff developments contributed to a $524,000 Q1 net loss and a reduced gross margin.